The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Toxoplasmosis Testing Market Research Report 2025
Synopsis
The term toxoplasmosis refers to the infectious disease caused by the parasite Toxoplasma gondii. It may cause acute or chronic infection.
The global Toxoplasmosis Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Currently, North America dominates the global toxoplasmosis testing market, followed by Europe. This is due to the rising prevalence of infectious diseases and increasing demand for effective testing methods by diagnostics laboratories in these regions.
This report aims to provide a comprehensive presentation of the global market for Toxoplasmosis Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Toxoplasmosis Testing.
Report Scope
The Toxoplasmosis Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Toxoplasmosis Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Toxoplasmosis Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Affymetrix
Bio-Rad Laboratories
Beckman Coulter
Biomerica
Cepheid
Biotest
GenBio
Segment by Type
Testing Equipment
Reagent Consumables
Segment by Application
Hospitals
Commercial Or Private Laboratories
Physician Offices
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Toxoplasmosis Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The term toxoplasmosis refers to the infectious disease caused by the parasite Toxoplasma gondii. It may cause acute or chronic infection.
The global Toxoplasmosis Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Currently, North America dominates the global toxoplasmosis testing market, followed by Europe. This is due to the rising prevalence of infectious diseases and increasing demand for effective testing methods by diagnostics laboratories in these regions.
This report aims to provide a comprehensive presentation of the global market for Toxoplasmosis Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Toxoplasmosis Testing.
Report Scope
The Toxoplasmosis Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Toxoplasmosis Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Toxoplasmosis Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Affymetrix
Bio-Rad Laboratories
Beckman Coulter
Biomerica
Cepheid
Biotest
GenBio
Segment by Type
Testing Equipment
Reagent Consumables
Segment by Application
Hospitals
Commercial Or Private Laboratories
Physician Offices
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Toxoplasmosis Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Toxoplasmosis Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Testing Equipment
1.2.3 Reagent Consumables
1.3 Market by Application
1.3.1 Global Toxoplasmosis Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Commercial Or Private Laboratories
1.3.4 Physician Offices
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Toxoplasmosis Testing Market Perspective (2019-2030)
2.2 Toxoplasmosis Testing Growth Trends by Region
2.2.1 Global Toxoplasmosis Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Toxoplasmosis Testing Historic Market Size by Region (2019-2024)
2.2.3 Toxoplasmosis Testing Forecasted Market Size by Region (2025-2030)
2.3 Toxoplasmosis Testing Market Dynamics
2.3.1 Toxoplasmosis Testing Industry Trends
2.3.2 Toxoplasmosis Testing Market Drivers
2.3.3 Toxoplasmosis Testing Market Challenges
2.3.4 Toxoplasmosis Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Toxoplasmosis Testing Players by Revenue
3.1.1 Global Top Toxoplasmosis Testing Players by Revenue (2019-2024)
3.1.2 Global Toxoplasmosis Testing Revenue Market Share by Players (2019-2024)
3.2 Global Toxoplasmosis Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Toxoplasmosis Testing Revenue
3.4 Global Toxoplasmosis Testing Market Concentration Ratio
3.4.1 Global Toxoplasmosis Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Toxoplasmosis Testing Revenue in 2023
3.5 Toxoplasmosis Testing Key Players Head office and Area Served
3.6 Key Players Toxoplasmosis Testing Product Solution and Service
3.7 Date of Enter into Toxoplasmosis Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Toxoplasmosis Testing Breakdown Data by Type
4.1 Global Toxoplasmosis Testing Historic Market Size by Type (2019-2024)
4.2 Global Toxoplasmosis Testing Forecasted Market Size by Type (2025-2030)
5 Toxoplasmosis Testing Breakdown Data by Application
5.1 Global Toxoplasmosis Testing Historic Market Size by Application (2019-2024)
5.2 Global Toxoplasmosis Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Toxoplasmosis Testing Market Size (2019-2030)
6.2 North America Toxoplasmosis Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Toxoplasmosis Testing Market Size by Country (2019-2024)
6.4 North America Toxoplasmosis Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Toxoplasmosis Testing Market Size (2019-2030)
7.2 Europe Toxoplasmosis Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Toxoplasmosis Testing Market Size by Country (2019-2024)
7.4 Europe Toxoplasmosis Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Toxoplasmosis Testing Market Size (2019-2030)
8.2 Asia-Pacific Toxoplasmosis Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Toxoplasmosis Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Toxoplasmosis Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Toxoplasmosis Testing Market Size (2019-2030)
9.2 Latin America Toxoplasmosis Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Toxoplasmosis Testing Market Size by Country (2019-2024)
9.4 Latin America Toxoplasmosis Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Toxoplasmosis Testing Market Size (2019-2030)
10.2 Middle East & Africa Toxoplasmosis Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Toxoplasmosis Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Toxoplasmosis Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Toxoplasmosis Testing Introduction
11.1.4 Abbott Laboratories Revenue in Toxoplasmosis Testing Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Affymetrix
11.2.1 Affymetrix Company Detail
11.2.2 Affymetrix Business Overview
11.2.3 Affymetrix Toxoplasmosis Testing Introduction
11.2.4 Affymetrix Revenue in Toxoplasmosis Testing Business (2019-2024)
11.2.5 Affymetrix Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Toxoplasmosis Testing Introduction
11.3.4 Bio-Rad Laboratories Revenue in Toxoplasmosis Testing Business (2019-2024)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Detail
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Toxoplasmosis Testing Introduction
11.4.4 Beckman Coulter Revenue in Toxoplasmosis Testing Business (2019-2024)
11.4.5 Beckman Coulter Recent Development
11.5 Biomerica
11.5.1 Biomerica Company Detail
11.5.2 Biomerica Business Overview
11.5.3 Biomerica Toxoplasmosis Testing Introduction
11.5.4 Biomerica Revenue in Toxoplasmosis Testing Business (2019-2024)
11.5.5 Biomerica Recent Development
11.6 Cepheid
11.6.1 Cepheid Company Detail
11.6.2 Cepheid Business Overview
11.6.3 Cepheid Toxoplasmosis Testing Introduction
11.6.4 Cepheid Revenue in Toxoplasmosis Testing Business (2019-2024)
11.6.5 Cepheid Recent Development
11.7 Biotest
11.7.1 Biotest Company Detail
11.7.2 Biotest Business Overview
11.7.3 Biotest Toxoplasmosis Testing Introduction
11.7.4 Biotest Revenue in Toxoplasmosis Testing Business (2019-2024)
11.7.5 Biotest Recent Development
11.8 GenBio
11.8.1 GenBio Company Detail
11.8.2 GenBio Business Overview
11.8.3 GenBio Toxoplasmosis Testing Introduction
11.8.4 GenBio Revenue in Toxoplasmosis Testing Business (2019-2024)
11.8.5 GenBio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
